Anticancer Fund, Brussels, 1853 Strombeek-Bever, Belgium.
The George Pantziarka TP53 Trust, London KT1 2JP, UK.
Future Oncol. 2019 Nov;15(31):3597-3608. doi: 10.2217/fon-2019-0233. Epub 2019 Oct 29.
To investigate secular trends in article retractions in the oncology literature, particularly relating to cancer treatments and data available to patients. A bibliometric analysis of article retractions from PubMed in the period 2000-2018. Analysis shows that article lifetime - that is the time period from initial publication to ultimate retraction - has decreased in recent years. It also shows that the retraction rate has also increased over the same period. Furthermore, over 20% of retracted oncology publications analyzed in this study relate to treatment-relevant topics such as clinical trials and studies in the anticancer properties of supplements. The causes and context of these trends are discussed and reference made to the dangers of scientific misconduct in oncology.
为了研究肿瘤学文献中文章撤稿的长期趋势,特别是与癌症治疗和患者可获得的数据相关的撤稿趋势。本研究对 2000 年至 2018 年间 PubMed 中文章撤稿进行了文献计量分析。分析结果显示,文章的寿命(即从首次发表到最终撤稿的时间段)近年来有所缩短。此外,同一时期的撤稿率也有所增加。此外,本研究分析的 20%以上的撤稿肿瘤学出版物涉及与治疗相关的主题,如临床试验和补充剂抗癌特性的研究。讨论了这些趋势的原因和背景,并提到了肿瘤学中科学不端行为的危险。